BPIQ Blog

Summary TBPH reporting TD-9855 data in nOH by end of July Medium risk and reward opportunity TBPH July data for wholly owned TD-9855...

Zogenix (ZGNX) is set to imminently release additional phase 3 data from its trial with its drug ZX008 (low dose fenfluramine) for...

Looking forward to Global Blood Therapeutics report out of Part A from their Phase 3 Hope study of their drug voxelotor (formerly GBT440)...